Product category
Diabetes & Metabolic Medicines
4 public development records. Search this category and review proposed presentations, evidence limits and attributed references.
- Records
- 4
- Medicines
- 4
- Devices / diagnostics
- 0
- Presentations represented
- 1
Public development records
Diabetes & Metabolic Medicines records
Category placement supports navigation. It does not establish an approved indication, suitability for a particular patient group, prescription status or eligibility for supply.
Showing 4 of 4 records
Portfolio records
| Record | Dosage form / type | Proposed strength / configuration | Proposed pack | Status |
|---|---|---|---|---|
| Glibenclamide TabletsLP-058 | TabletMedicine | 5 mg | Blister 10 x 10 tablets | Development record |
| Gliclazide TabletsLP-059 | TabletMedicine | 80 mg immediate-release; 30 mg modified-release; 60 mg modified-release | Blister 10 x 10 tablets | Development record |
| Glipizide TabletsLP-060 | TabletMedicine | 5 mg; 10 mg | Blister 10 x 10 tablets | Development record |
| Metformin TabletsLP-061 | TabletMedicine | 500 mg; 850 mg; 1000 mg | Blister 10 x 10 tablets | Development record |
No matching record.
Try a broader generic name, another presentation or a portfolio reference.
Professional enquiries
Enquire about this product category.
Include the generic name or portfolio reference, your organisation and destination country.